Chiara Baldini Selected Research

Leukopenia

1/2021	Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome.
1/2020	Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
5/2018	Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
8/2014	Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?
6/2014	Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
3/2013	Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
4/2006	Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara Baldini Research Topics

Disease

11	Lymphoma (Lymphomas) 01/2022 - 11/2011
7	Leukopenia 01/2021 - 04/2006
5	Autoimmune Diseases (Autoimmune Disease) 05/2022 - 02/2014
5	Infections 01/2021 - 05/2002
5	Rheumatic Diseases (Rheumatism) 01/2021 - 05/2007
4	Vasculitis (Vasculitides) 01/2022 - 06/2014
4	COVID-19 01/2021 - 01/2020
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2015 - 04/2006
4	Systemic Scleroderma (Systemic Sclerosis) 03/2013 - 10/2007
3	Dry Eye Syndromes (Dry Eye Syndrome) 10/2021 - 07/2015
3	Cryoglobulinemia 01/2021 - 05/2002
3	Sjogren's Syndrome (Sjogren Syndrome) 01/2021 - 01/2011
3	Purpura 01/2021 - 03/2013
3	Neoplasms (Cancer) 01/2021 - 05/2019
3	Fatigue 01/2021 - 03/2013
3	Lymphadenopathy 01/2020 - 01/2017
3	Inflammation (Inflammations) 01/2019 - 05/2007
3	Systemic Vasculitis 03/2018 - 01/2012
3	Rheumatoid Arthritis 02/2012 - 03/2010
2	Myositis (Idiopathic Inflammatory Myopathies) 05/2022 - 07/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022 - 01/2020
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 11/2019
2	Necrosis 11/2021 - 12/2020
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 01/2019
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2020 - 11/2015
2	Arthritis (Polyarthritis) 07/2015 - 04/2006
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 09/2008 - 10/2007
1	Myalgia 05/2022
1	Splenomegaly 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Fever (Fevers) 01/2021
1	Cough 01/2021
1	Cataract (Cataracts) 01/2021
1	Lung Neoplasms (Lung Cancer) 07/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2020
1	Sialadenitis 07/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Pain (Aches) 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 05/2018
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2017
1	Microscopic Polyangiitis 01/2017
1	Xerostomia 01/2017
1	Asthma (Bronchial Asthma) 05/2016
1	Eosinophilia 05/2016
1	Bronchial Hyperreactivity 05/2016
1	Proteinuria 10/2015

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
8	AntibodiesIBA 05/2022 - 04/2006
7	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2007
5	Biological ProductsIBA 01/2022 - 11/2009
5	Rheumatoid FactorIBA 07/2020 - 03/2013
4	CryoglobulinsIBA 05/2018 - 06/2014
3	CytokinesIBA 11/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 04/2006
2	Antiviral Agents (Antivirals)IBA 01/2020 - 05/2002
2	AutoantibodiesIBA 01/2020 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2019
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2019 - 01/2017
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019 - 10/2015
2	anti-dsDNA autoantibodyIBA 10/2015 - 04/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2011 - 04/2007
1	Biological FactorsIBA 05/2022
1	mepolizumabIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Protein Kinases (Protein Kinase)IBA 11/2021
1	InterleukinsIBA 11/2021
1	SteroidsIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	Ophthalmic Solutions (Eye Drops)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	interleukin-21 (interleukin 21)IBA 12/2020
1	mesoglycanIBA 07/2020
1	Thymic Stromal LymphopoietinIBA 07/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2020
1	nilotinib FDA Link 01/2020
1	HLA-DQ Antigens (HLA-DQ)IBA 11/2019
1	Immune Checkpoint InhibitorsIBA 05/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	ElementsIBA 05/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Myeloblastin (Proteinase 3)IBA 01/2017
1	Salivary CystatinsIBA 01/2017
1	Sodium Glutamate (Accent)IBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2016
1	Temazepam (Nocturne)FDA LinkGeneric 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2015
1	Methotrexate (Mexate)FDA LinkGeneric 07/2015
1	Pharmaceutical PreparationsIBA 07/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2012
2	Lasers (Laser) 07/2015 - 03/2013
1	Polypharmacy 01/2021
1	Electronic Nose 07/2020
1	Immunotherapy 05/2019